Assessing e-cigarette product compliance to the TPD

The most popular e-liquid websites and their marketed brands, in 9 European countries (Greece, France, Poland, Germany, Holland, the United Kingdom, Spain, Romania and Hungary) were identified and 122 products in total were bought. We evaluated the different types of labelling information and warnings that may be included either within or on the packaging and leaflet of the products, assessed technical design/safety features and evaluated the chemical composition of e-cigarettes. There is a good compliance level of the products in specific technical design/safety characteristics such as nicotine content ≤20 ml, child proof vial, list of ingredients which varied among countries while refill mechanism requirements implementation was poor among products. As for chemical evaluation of the products, several respiratory irritants and discrepancies in the reported vs. measured nicotine content of e-liquids were identified.

Funding This work was supported by a grant from the European Commission (Horizon2020 HCO-6-2015; EUREST-PLUS: 681109).

Submit your paper

Instructions to Authors

Home

Send by email

Patient–provider communication about cigarette and e-cigarette use during pregnancy: Adaptation and validation of frequency and quality of communication measures among a sample of pregnant patients

Session on tobacco and e-cigarette use and urological cancers: major conclusions on the risk, beliefs and behaviors, preventive recommendations

E-cigarette use and the potential risk for bladder cancer

Perceived content, relationship with tobacco and self-reported reasons for e-cigarette use among adolescents in Europe - findings from ESPAD 2019

A scoping review on e-cigarette environmental impacts

Indexes

Keywords index

Topics index

Authors index

eISSN:

2459-3087

On behalf of the European Network of Smoking and Tobacco Prevention. Chausse d'lxelles 144, Brussels, Belgium.
Published by European Publishing. Science and Technology Park of Crete (STEP-C). Vassilika Vouton, GR-70013 Heraklion, Crete, Greece

This journal is currently funded by the Health Programme of the European Union
Neither the European Commission nor any person acting on behalf of the European Commission is responsible for the use which might be made of the information contained herein. The views in this publication are those of the author and do not necessarily reflect the policies of the European Commission.

© 2024 European Publishing, unless otherwise stated.
The views and opinions expressed in the published articles are strictly those of the author(s). 21 December 2021.